Quantum Genesis AI Corp. (OTC: QGAI) announced today that the Caveat Emptor designation previously applied to its securities by OTC Markets Group has been removed, according to a press release from the company.
The Caveat Emptor designation, which alerts investors to potential issues with a company’s public disclosure or suspicious trading activity, was removed after OTC Markets completed a review process. The company stated that it worked cooperatively with OTC Markets to provide information and respond to inquiries during the review period.
“We appreciate the time and attention that OTC Markets dedicated to this matter and are pleased that the review process has concluded with the removal of the Caveat Emptor designation,” said Naveen Kulkarni, Chief Executive Officer of Quantum Genesis AI Corp. “Throughout this process, our focus remained on transparency, responsiveness, and constructive engagement.”
The removal of the designation is a significant milestone for the company, which had been operating under the stigma of the Caveat Emptor label. Such a designation can deter investors and limit trading activity. With the label removed, Quantum Genesis AI may regain investor confidence and potentially see increased liquidity in its stock.
Quantum Genesis AI is focused on advancing technologies at the intersection of artificial intelligence, computational modeling, and scientific innovation. The company says it remains committed to responsible corporate governance and public company compliance, and it intends to provide timely updates regarding its business activities through public disclosures and shareholder communications.
For more information, visit the company’s website at www.qgaicorp.com and its profile on www.otcmarkets.com/stock/QGAI.
